Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny M Cohn

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Journal of Asthma and Allergy|March 2, 2026
Donidalorsen for Long-Term Prophylaxis of Hereditary Angioedema Attacks: Results from the OASISplus Open-Label Extension Cohort at Year 1William R Lumry, Raffi Tachdjian, Timothy Craig, et al.
Clinical and Translational Allergy|March 4, 2026
An International Delphi Study on Barriers to On-Demand Treatment of Hereditary Angioedema AttacksAleena Banerji, Emel Aygören-Pürsün, Noemi-Anna Bara, et al.
The New England Journal of Medicine|June 15, 2026
Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary AngioedemaDanny M Cohn, Padmalal Gurugama, Hilary J Longhurst, et al.
The New England Journal of Medicine|January 31, 2024
CRISPR-Cas9 In Vivo Gene Editing of <i>KLKB1</i> for Hereditary AngioedemaHilary J Longhurst, Karen Lindsay, Remy S Petersen, et al.
Clinical and Translational Allergy|November 18, 2025
Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-SJonathan A Bernstein, Emel Aygören-Pürsün, Mauro Cancian, et al.
Lancet (London, England)|February 11, 2023
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trialEmel Aygören-Pürsün, Andrea Zanichelli, Danny M Cohn, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 5, 2026
Impact of Oral Sebetralstat on Anxiety Associated With Hereditary Angioedema AttacksTimothy Craig, Emel Aygören-Pürsün, Jonathan A Bernstein, et al.
Allergy|January 30, 2026
International Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary AngioedemaHenriette Farkas, Inmaculada Martinez-Saguer, Konrad Bork, et al.
The New England Journal of Medicine|May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema AttacksMarc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.
Arerugi = [Allergy]|April 12, 2026
Bruce L Zuraw, Konrad Bork, Laurence Bouillet, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Journal of Asthma and Allergy|March 2, 2026
Donidalorsen for Long-Term Prophylaxis of Hereditary Angioedema Attacks: Results from the OASISplus Open-Label Extension Cohort at Year 1William R Lumry, Raffi Tachdjian, Timothy Craig, et al.
Clinical and Translational Allergy|March 4, 2026
An International Delphi Study on Barriers to On-Demand Treatment of Hereditary Angioedema AttacksAleena Banerji, Emel Aygören-Pürsün, Noemi-Anna Bara, et al.
The New England Journal of Medicine|June 15, 2026
Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary AngioedemaDanny M Cohn, Padmalal Gurugama, Hilary J Longhurst, et al.
The New England Journal of Medicine|January 31, 2024
CRISPR-Cas9 In Vivo Gene Editing of <i>KLKB1</i> for Hereditary AngioedemaHilary J Longhurst, Karen Lindsay, Remy S Petersen, et al.
Clinical and Translational Allergy|November 18, 2025
Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-SJonathan A Bernstein, Emel Aygören-Pürsün, Mauro Cancian, et al.
Lancet (London, England)|February 11, 2023
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trialEmel Aygören-Pürsün, Andrea Zanichelli, Danny M Cohn, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 5, 2026
Impact of Oral Sebetralstat on Anxiety Associated With Hereditary Angioedema AttacksTimothy Craig, Emel Aygören-Pürsün, Jonathan A Bernstein, et al.
Allergy|January 30, 2026
International Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary AngioedemaHenriette Farkas, Inmaculada Martinez-Saguer, Konrad Bork, et al.
The New England Journal of Medicine|May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema AttacksMarc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.
Arerugi = [Allergy]|April 12, 2026
Bruce L Zuraw, Konrad Bork, Laurence Bouillet, et al.
Pageof 9